Screening of important metabolites and KRAS genotypes in colon cancer using secondary ion mass spectrometry

Kookrae Cho1, Eun-Sook Choi2, Sung Young Lee3

  • 1Division of Electronic Information System Research Daegu Gyeongbuk Institute of Science and Technology (DGIST) Daegu Republic of Korea.

Insights

Time-of-flight secondary ion mass spectrometry (TOF-SIMS) identified key metabolites and KRAS mutations in colorectal cancer (CRC). This technique offers a novel diagnostic tool for analyzing frozen tissue slides in biomedical tests.

Area of Science:

  • Biomaterial surface characterization
  • Analytical chemistry
  • Molecular imaging

Background:

  • Colorectal cancer (CRC) diagnosis relies on identifying specific molecular markers.
  • Current diagnostic methods may require invasive procedures or extensive sample processing.
  • Need for rapid, simultaneous detection of metabolic and genetic biomarkers in CRC.

Purpose of the Study:

  • To utilize Time-of-flight secondary ion mass spectrometry (TOF-SIMS) for identifying diagnostic biomarkers in colorectal cancer.
  • To develop a machine learning-based approach for analyzing TOF-SIMS spectral data for CRC classification and KRAS mutation detection.
  • To assess the potential of TOF-SIMS as a diagnostic tool for clinical applications using frozen tissue slides.

Main Methods:

  • Acquisition of 540 TOF-SIMS spectra from 180 human colorectal cancer cryo-sections.
  • Dimensionality reduction using Principal Component Analysis (PCA) on spectral data.
  • Classification of samples using Support Vector Machine (SVM) algorithm with PCA components, evaluated by Receiver Operating Characteristic (ROC) Area Under the Curve (AUC).

Main Results:

  • Identification of discriminatory molecules including arginine, α-tocopherol, and glycerophosphocholine fragments differentiating normal and tumor tissues (AUC=0.9297).
  • Pathway analysis indicated involvement of these molecules in gastrointestinal disease and organismal abnormalities.
  • Successful classification of spectra based on KRAS somatic mutation expression with high accuracy (AUC=0.9921).

Conclusions:

  • TOF-SIMS efficiently screens for both metabolite biomarkers and performs KRAS genotyping simultaneously in colorectal cancer.
  • A machine learning algorithm applied to TOF-SIMS spectral data from frozen tissue slides shows promise as a diagnostic tool.
  • This approach offers a potential advancement in the rapid and comprehensive molecular characterization of clinical samples.

Related Concept Videos